Drugs that contain Triamcinolone Acetonide
1. Drug name - TRIESENCE
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8211880 | NOVARTIS | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
Mar, 2029
(6 years from now) | |
| US8128960 | NOVARTIS | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
Dec, 2029
(7 years from now) | |
Treatment: Visualization during vitrectomy procedures; treatment of ophthalmic disorders
Dosage: INJECTABLE;INTRAVITREAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 40MG/ML (40MG/ML) | INJECTABLE;INTRAVITREAL | Prescription |
2. Drug name - XIPERE
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8636713 | BAUSCH AND LOMB INC | Methods and devices for drug delivery to ocular tissue using microneedle |
May, 2027
(4 years from now) | |
| US9636332 | BAUSCH AND LOMB INC | Methods and devices for the treatment of ocular diseases in human subjects |
Nov, 2033
(11 years from now) | |
| US9937075 | BAUSCH AND LOMB INC | Apparatus and methods for ocular injection |
May, 2034
(11 years from now) | |
Treatment: Treatment of macular edema associated with uveitis
Dosage: SUSPENSION;INJECTION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 40MG/ML | SUSPENSION;INJECTION | Prescription |
3. Drug name - ZILRETTA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9555048 | PACIRA PHARMS INC | Corticosteroids for the treatment of joint pain |
Aug, 2031
(8 years from now) | |
| US8828440 | PACIRA PHARMS INC | Corticosteroids for the treatment of joint pain |
Aug, 2031
(8 years from now) | |
Treatment: Method of treating pain or inflammation with an injectable controlled or sustained release formulation of triamcinolone acetonide
Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 32MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.